US Stock MarketDetailed Quotes

Camp4 Therapeutics (CAMP)

Watchlist
  • 5.620
  • -0.160-2.77%
Close Jan 16 16:00 ET
  • 5.620
  • 0.0000.00%
Post 16:04 ET
291.57MMarket Cap-4.93P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Camp4 Therapeutics (CAMP) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
795K
1.5M
858K
86.29%652K
652K
0
0
0
350K
0
Operating revenue
--795K
--1.5M
--858K
86.29%652K
--652K
--0
--0
--0
--350K
--0
Cost of revenue
Gross profit
Operating expense
3.23%13.95M
14.71%14.53M
8.41%13.96M
2.89%53.74M
8.98%14.69M
6.53%13.52M
12.66M
12.88M
16.06%52.23M
13.48M
Selling and administrative expenses
20.50%4.6M
27.77%4.18M
21.59%3.81M
28.50%14.92M
66.61%4.69M
32.94%3.81M
--3.27M
--3.14M
13.52%11.61M
--2.82M
-General and administrative expense
20.50%4.6M
27.77%4.18M
21.59%3.81M
28.50%14.92M
66.61%4.69M
32.94%3.81M
--3.27M
--3.14M
13.52%11.61M
--2.82M
Research and development costs
-3.57%9.36M
10.16%10.34M
4.17%10.15M
-4.43%38.82M
-6.24%10M
-1.19%9.7M
--9.39M
--9.74M
16.81%40.62M
--10.66M
Operating profit
2.66%-13.16M
-2.89%-13.03M
-1.75%-13.1M
-2.33%-53.09M
-4.14%-14.03M
-9.55%-13.52M
-12.66M
-12.88M
-15.28%-51.88M
-13.48M
Net non-operating interest income expense
350.00%423K
96.10%453K
48.86%588K
-52.64%1.33M
7.21%610K
-86.36%94K
231K
395K
210.62%2.81M
569K
Non-operating interest income
350.00%423K
96.10%453K
48.86%588K
-52.64%1.33M
7.21%610K
-86.36%94K
--231K
--395K
210.62%2.81M
--569K
Other net income (expense)
-3,714.52%-2.37M
91.72%-12K
182.14%79K
85.00%-33K
274.70%145K
-31.91%-62K
-145K
28K
-131.58%-220K
-83K
Gain on sale of security
---1.8M
----
----
----
----
----
----
----
----
----
Special income (charges)
---494K
----
----
----
----
--0
----
----
----
----
-Less:Impairment of capital assets
--494K
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
-14.52%-71K
91.72%-12K
182.14%79K
85.00%-33K
274.70%145K
-31.91%-62K
---145K
--28K
-131.58%-220K
---83K
Income before tax
-11.98%-15.1M
-0.09%-12.59M
0.15%-12.43M
-5.07%-51.79M
-2.22%-13.28M
-15.29%-13.48M
-12.58M
-12.45M
-11.54%-49.29M
-12.99M
Income tax
Net income
-11.98%-15.1M
-0.09%-12.59M
0.15%-12.43M
-5.07%-51.79M
-2.22%-13.28M
-15.29%-13.48M
-12.58M
-12.45M
-11.54%-49.29M
-12.99M
Net income continuous Operations
-11.98%-15.1M
-0.09%-12.59M
0.15%-12.43M
-5.07%-51.79M
-2.22%-13.28M
-15.29%-13.48M
---12.58M
---12.45M
-11.54%-49.29M
---12.99M
Minority interest income
Net income attributable to the parent company
-11.98%-15.1M
-0.09%-12.59M
0.15%-12.43M
-5.07%-51.79M
-2.22%-13.28M
-15.29%-13.48M
-12.58M
-12.45M
-11.54%-49.29M
-12.99M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-11.98%-15.1M
-0.09%-12.59M
0.15%-12.43M
-5.07%-51.79M
-2.22%-13.28M
-15.29%-13.48M
-12.58M
-12.45M
-11.54%-49.29M
-12.99M
Basic earnings per share
20.44%-0.55
3.84%-0.62
39.63%-0.62
-171.57%-11.04
38.52%-0.6586
28.34%-0.6913
-0.6448
-1.027
-11.54%-4.0653
-1.0714
Diluted earnings per share
20.44%-0.55
3.84%-0.62
39.63%-0.62
-171.57%-11.04
38.52%-0.6586
28.34%-0.6913
-0.6448
-1.027
-11.54%-4.0653
-1.0714
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 795K1.5M858K86.29%652K652K000350K0
Operating revenue --795K--1.5M--858K86.29%652K--652K--0--0--0--350K--0
Cost of revenue
Gross profit
Operating expense 3.23%13.95M14.71%14.53M8.41%13.96M2.89%53.74M8.98%14.69M6.53%13.52M12.66M12.88M16.06%52.23M13.48M
Selling and administrative expenses 20.50%4.6M27.77%4.18M21.59%3.81M28.50%14.92M66.61%4.69M32.94%3.81M--3.27M--3.14M13.52%11.61M--2.82M
-General and administrative expense 20.50%4.6M27.77%4.18M21.59%3.81M28.50%14.92M66.61%4.69M32.94%3.81M--3.27M--3.14M13.52%11.61M--2.82M
Research and development costs -3.57%9.36M10.16%10.34M4.17%10.15M-4.43%38.82M-6.24%10M-1.19%9.7M--9.39M--9.74M16.81%40.62M--10.66M
Operating profit 2.66%-13.16M-2.89%-13.03M-1.75%-13.1M-2.33%-53.09M-4.14%-14.03M-9.55%-13.52M-12.66M-12.88M-15.28%-51.88M-13.48M
Net non-operating interest income expense 350.00%423K96.10%453K48.86%588K-52.64%1.33M7.21%610K-86.36%94K231K395K210.62%2.81M569K
Non-operating interest income 350.00%423K96.10%453K48.86%588K-52.64%1.33M7.21%610K-86.36%94K--231K--395K210.62%2.81M--569K
Other net income (expense) -3,714.52%-2.37M91.72%-12K182.14%79K85.00%-33K274.70%145K-31.91%-62K-145K28K-131.58%-220K-83K
Gain on sale of security ---1.8M------------------------------------
Special income (charges) ---494K------------------0----------------
-Less:Impairment of capital assets --494K------------------0----------------
Other non- operating income (expenses) -14.52%-71K91.72%-12K182.14%79K85.00%-33K274.70%145K-31.91%-62K---145K--28K-131.58%-220K---83K
Income before tax -11.98%-15.1M-0.09%-12.59M0.15%-12.43M-5.07%-51.79M-2.22%-13.28M-15.29%-13.48M-12.58M-12.45M-11.54%-49.29M-12.99M
Income tax
Net income -11.98%-15.1M-0.09%-12.59M0.15%-12.43M-5.07%-51.79M-2.22%-13.28M-15.29%-13.48M-12.58M-12.45M-11.54%-49.29M-12.99M
Net income continuous Operations -11.98%-15.1M-0.09%-12.59M0.15%-12.43M-5.07%-51.79M-2.22%-13.28M-15.29%-13.48M---12.58M---12.45M-11.54%-49.29M---12.99M
Minority interest income
Net income attributable to the parent company -11.98%-15.1M-0.09%-12.59M0.15%-12.43M-5.07%-51.79M-2.22%-13.28M-15.29%-13.48M-12.58M-12.45M-11.54%-49.29M-12.99M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -11.98%-15.1M-0.09%-12.59M0.15%-12.43M-5.07%-51.79M-2.22%-13.28M-15.29%-13.48M-12.58M-12.45M-11.54%-49.29M-12.99M
Basic earnings per share 20.44%-0.553.84%-0.6239.63%-0.62-171.57%-11.0438.52%-0.658628.34%-0.6913-0.6448-1.027-11.54%-4.0653-1.0714
Diluted earnings per share 20.44%-0.553.84%-0.6239.63%-0.62-171.57%-11.0438.52%-0.658628.34%-0.6913-0.6448-1.027-11.54%-4.0653-1.0714
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.35%
Sample Name
Sample Code
 +10.03%
Sample Name
Sample Code
 +9.57%
4
Kingsoft Cloud
KC
+7.99%
5
United Microelectronics
UMC
+5.80%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -